Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion

Cancer Research

Volumn 57, Issue 4, 1997, Pages 604-609

  Gray Bablin, Julie ^a   Rao, Sharmila ^a   Keyomarsi, Khandan ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MEVINOLIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; DRUG EFFECT; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR GROWTH;

BREAST; BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; FEMALE; HUMANS; LOVASTATIN; MICROTUBULE-ASSOCIATED PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031053093     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Draetta, G. cdc2 activation; the interplay of cyclin binding and Thr161 phosphorylation. Trends Cell Biol., 3: 287-289, 1993.
2. Pines, J. The cell cycle kinases. Semin. Cancer Biol., 5: 305-313, 1994.
3. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell, 79: 573-582, 1994.
4. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
5. Peter, M., and Herskowitz, I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell, 79: 181-184, 1994.
6. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
7. Elledge, S. J., and Harper, J. W. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol., 6: 847-852, 1994.
8. Elledge, S. J., Winston, J., and Harper, J. W. A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol., 6: 388-392, 1996.
9. Hengst, L., Dulic, V., Slingerland, J. M., Lees, E., and Reed, S. I. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA, 91: 5291-5295, 1994.
10. Hengst, L., and Reed, S. I. Translational control of p27Kip1 accumulation during the cell cycle. Science (Washington DC), 277: 1861-1864, 1996.
11. Jakobisiak, M., Bruno, S., Skierski, J. S., and Darzynkiewicz, Z. Cell cycle- specific effects of lovastatin. Proc. Natl. Acad. Sci. USA, 88: 3628-3632, 1991.
12. 1 to multiple cell cycles by lovastatin. Cancer Res., 51: 3602-3609, 1991.
13. Keyomarsi, K. Synchronization of mammalian cells by lovastatin. Methods Cell Sci., 18: 1-6, 1996.
14. Turner, J. E., Minkoff, C. G., Martin, K. H., Misra, R., and Swenson, K. I. Oocyte activation and passage through the metaphase/anaphase transition of the meiotic cell cycle is blocked in clams by inhibitors of HMG-CoA reductase activity. J. Cell Biol., 725: 1145-1162, 1995.
15. Keyomarsi, K., and Pardee, A. B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA, 90: 1112-1116, 1993.
16. Keyomarsi, K., Conte, D., Toyofuku, W., and Fox, M. P. Deregulation of cyclin E in breast cancer. Oncogene, 11: 941-950, 1995.
17. Band, V., and Sager, R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA, 86: 1249-1253, 1989.
18. Rao, P. N., and Johnson, R. T. Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis. Nature (Lond.), 225: 159-164, 1970.
19. Michalopoulos, G. K. Liver regeneration: molecular mechanisms of growth control. FASEB J., 4: 176-187, 1990.
20. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H. J., and Pardee, A. B. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54: 380-385, 1994.
21. Bacus, S. S., Yarden, Y., Oren, M., Chin, D. M., Lyass, L., Zelnick, C. R., Kazarov, A., Toyofuku, W., Gray-Bablin, J., Beerli, R. R., Hynes, N. E., Nikiforov, M., Haffner, R., Gudkov, A., and Keyomarsi, K. Neu differentiation factor (heregulin) activates a p53-dependent pathway in cancer cells. Oncogene, 72: 2535-2547, 1996.
22. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6075-6086, 1990.
23. Gray-Bablin, J., Zalvide, J., Fox, M. P., Knickerbocker, C. J., DeCaprio, J. A., and Keyomarsi, K. Cyclin E, a redundant cyclin in breast cancer. Proc. Natl. Acad. Sci. USA, 93: 15215-15220, 1996.
24. Massague, J., and Polyak, K. Mammalian anti-proliferative signals and their targets. Curr. Opin. Genet. Dev., 5: 91-96, 1995.
25. 0 state) in fibroblasts. J. Biol. Chem 277: 18337-18341, 1996.
26. Maltese, W. A. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J., 4: 3319-3328, 1990.
27. Maltese, W. A., and Sheridan, K. M. Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J. Cell. Physiol., 133: 471-481, 1987.